Myriad Genetics, Inc.
Symbol: MYGN
NASDAQ
21.6
USDTrhová cena dnes
-7.5210
Pomer P/E
-0.4011
Pomer PEG
1.94B
MRK Cap
- 0.00%
Výnos DIV
Myriad Genetics, Inc. (MYGN) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 114.9 | 339.8 | 136.9 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 58 | 81.4 | 43.7 | |||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 101.6 | 91.3 | 138.6 | |||||||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 20.1 | 15.3 | 31.4 | |||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 20.4 | 38.4 | 41.7 | |||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 274.6 | 484.8 | 348.6 | |||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 187.3 | 125.3 | 57.3 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 286.8 | 239.2 | 417.2 | |||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 379.7 | 404.1 | 684.7 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 666.5 | 643.3 | 1101.9 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 54.8 | 59 | 54.9 | |||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 15.5 | 8.3 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 924.1 | 835.9 | 1214.1 | |||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 1198.7 | 1320.7 | 1562.7 | |||||||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 28.8 | 29.6 | 33.3 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 14.1 | 13 | 78.9 | |||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 4.8 | 4 | 3 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 130.9 | 79.3 | 233.5 | |||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 93.7 | 156.5 | 3.4 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 175.7 | 148.6 | 356 | |||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 145 | 92.3 | 70.4 | |||||||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 312.9 | 352.9 | 473.8 | |||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.8 | 0.8 | 0.7 | |||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -366.2 | -254.2 | 25.6 | |||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -8.9 | -5.1 | -5.4 | |||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1260.1 | 1226.3 | 1068 | |||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 885.8 | 967.8 | 1088.9 | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1198.7 | 1320.7 | 1562.7 | |||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | - | - | - | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||||||
Total Investments | 0 | 112.8 | 140.4 | 98.6 | |||||||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 145 | 92.3 | 233.5 | |||||||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 88.1 | -166.1 | 140.3 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -112 | -27.2 | 4.6 | |||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 52.7 | 62.8 | 73 | |||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -31.9 | -34.7 | 13.1 | |||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 38.1 | 36.3 | 33.5 | |||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -101.5 | 120.4 | -37.1 | |||||||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -10.3 | -8.8 | -18.2 | |||||||||||||||||||||||||||
cash-flows.row.inventory | 0 | -2.9 | 1.6 | 8 | |||||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -3.5 | 9.2 | 1.1 | |||||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -84.8 | 118.4 | -28 | |||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 48.3 | -139.4 | -3.4 | |||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -45.3 | -18 | -8.6 | |||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -57.2 | 379.1 | -278.5 | |||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -103.2 | -147.8 | -78.5 | |||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 128.2 | 61.1 | 79.2 | |||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -77.5 | 274.4 | -286.4 | |||||||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -226.4 | -115 | |||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 6.3 | 91.8 | 8.7 | |||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | -50 | |||||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -340 | |||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -14.3 | -16 | 678.6 | |||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -8 | -150.6 | 182.3 | |||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -0.6 | -0.6 | 2.7 | |||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -192.4 | 141.4 | -17.7 | |||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 66.4 | 258.4 | 93.2 | |||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 258.8 | 117 | 110.9 | |||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -106.3 | 18.2 | 83.7 | |||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -45.3 | -18 | -8.6 | |||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -151.6 | 0.2 | 75.1 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 678.4 | 690.6 | 851.1 | |||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 202 | 197.6 | 201 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 476.4 | 493 | 650.1 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0.6 | 139.3 | 1.2 | |||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 600.1 | 681.7 | 641.4 | |||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 802.1 | 879.3 | 842.4 | |||||||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 2.6 | 0.7 | 3.2 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 3.2 | 6.6 | 12 | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -16.9 | -8.4 | 0.1 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.6 | 139.3 | 1.2 | |||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -16.9 | -8.4 | 0.1 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 3.2 | 6.6 | 12 | |||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 55.9 | 62.8 | 73 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -123.7 | -48.7 | 7.6 | |||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -140.6 | -57.1 | 0.2 | |||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -28.6 | -29.9 | -4.4 | |||||||||||||||||||||||||||
income-statement-row.row.net-income | 0 | -112 | -27.2 | 4.6 |
Často kladené otázky
Čo je Myriad Genetics, Inc. (MYGN) celkové aktíva?
Myriad Genetics, Inc. (MYGN) celkové aktíva sú 1198700000.000.
Aký je ročný obrat podniku?
Ročné príjmy sú N/A.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je 0.689.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je -1.692.
Aká je čistá zisková marža podniku?
Čistá zisková marža je -0.374.
Aké sú celkové výnosy podniku?
Celkové príjmy sú -0.370.
Aká je Myriad Genetics, Inc. (MYGN) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je -112000000.000.
Aký je celkový dlh firmy?
Celkový dlh je 145000000.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 600100000.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 0.000.